May 22, 2013 4:22 PM ET

Pharmaceuticals

Company Overview of Kolltan Pharmaceuticals, Inc.

Company Overview

Kolltan Pharmaceuticals, Inc., an oncology therapeutics company, develops monoclonal antibody drugs targeting receptor tyrosine kinases. The company was founded in 2007 and is based in New Haven, Connecticut.

300 George Street

Suite 530

New Haven, CT 06511

United States

Founded in 2007

Phone:

203-773-3000

Fax:

203-773-1300

www.kolltan.com

Key Executives for Kolltan Pharmaceuticals, Inc.

Chief Executive Officer and President
Age: 57
Co-Founder and Chairman of the Board
Age: 47
Co-Founder
Age: 67
Vice President of Finance and Treasurer
Chief Legal Officer
Age: 50
Compensation as of Fiscal Year 2012.

Kolltan Pharmaceuticals, Inc. Key Developments

Kolltan Pharmaceuticals Appoints Theresa M. Lavallee, Ph.D. as Vice President, Translational Medicine

Kolltan Pharmaceuticals announced the appointment of Theresa M. LaVallee, Ph.D., as Vice President, Translational Medicine, effective immediately. Dr. LaVallee will report to Jerry McMahon, Ph.D., Kolltan's President and Chief Executive Officer. Dr. LaVallee most recently served as Senior Director, Translational Medicine at MedImmune. At MedImmune, Dr. LaVallee designed and implemented translational and biomarker strategies for oncology drug development and was a key contributor to IND filings and early clinical development for many product candidates in oncology and inflammatory disease.

Kolltan Pharmaceuticals, Inc. Appoints Jane Henderson as Senior Vice President and Chief Business Officer

Kolltan Pharmaceuticals, Inc. announced the appointment of Jane Henderson as Senior Vice President and Chief Business Officer, effective immediately. Ms. Henderson will report to Gerald McMahon, Ph.D., Kolltan's President and Chief Executive Officer. Ms. Henderson has more than 24 years of experience in life sciences finance. She most recently served as Vice President, Business Development at ISTA Pharmaceuticals, Inc., where she managed the strategic option process that culminated in the successful acquisition of ISTA by Bausch + Lomb. She also oversaw the identification and evaluation of acquisitions and licensing opportunities and intellectual property strategy at ISTA. Previously, she was Executive Vice President, Chief Financial Officer and Chief Business Officer of Panacos Pharmaceuticals and served in similar roles at Axerion Therapeutics. Prior to these corporate positions, Ms. Henderson held senior investment banking positions for close to two decades in the health care groups of HSBC Securities, CIBC World Markets, Lehman Brothers and Salomon Brothers. Ms. Henderson represented clients on over 95 M&A and financing deals and attained the level of Managing Director of the Health Care Groups at HSBC and CIBC. Ms. Henderson serves as Secretary/Treasurer and Chairman of the Finance Committee on the Board of The EQUUS Foundation in Westport, CT.

Kolltan Pharmaceuticals, Inc. Presents at Boston Biotech Conference CEO New York Conference, Nov-02-2012 10:40 AM

Kolltan Pharmaceuticals, Inc. Presents at Boston Biotech Conference CEO New York Conference, Nov-02-2012 10:40 AM. Venue: Apella, 450 East 29th Street, New York, NY 10016, United States. Speakers: Jerry McMahon.

Similar Private Companies By Industry

Company Name Region
McCoy Enterprises LLC United States
Knopp Biosciences LLC United States
Anabase International Corp. United States
SphingoGene, Inc. United States
Watson Pharma, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kolltan Pharmaceuticals, Inc., please visit www.kolltan.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.